Progestrade (CLONE) Account Types & How to Open

When we set out to review the account types offered by the entity trading as Progestrade (CLONE), we expected to find the usual tiered structure—Standard, Premium, perhaps an ECN option—that most retail brokers present. Instead, our investigation hit a wall. The official domain, www.progestrade.com, is listed in our records, but the site itself is not verifiable in any meaningful way, and no independent user reviews exist to fill the gap. This is a familiar pattern for clone entities, which often borrow the name and branding of a legitimate firm while offering little or no actual trading infrastructure.

In FXCanary's assessment, the absence of verifiable account information is itself a critical finding. A legitimate broker will publish its account types, minimum deposits, spreads, and leverage prominently, because those are the terms of the contract a trader is about to enter. Progestrade (CLONE) does none of this in any record we can confirm. We cross-checked the domain against public registers and industry databases, but found no matching licence or regulatory filing. For a trader, this means that any account you might open—whether labelled 'Standard' or 'VIP'—would be operating without the safety net of regulatory oversight, and with no way to independently verify the terms you are being offered.

The most important fact about any trading account is not the spread or the leverage—it is the regulator standing behind it. Progestrade (CLONE) has no regulator on file. Our records show zero licences, and we found no evidence of registration with any financial authority in any jurisdiction. This is not a minor omission; it is a fundamental risk flag. When you open an account with an unregulated broker, you have no recourse if the broker disappears with your deposit, and no ombudsman to turn to if a trade is manipulated or a withdrawal is refused.

We compared this against the broader market. Most reputable brokers in Europe, Australia, or the UK hold at least one licence from a major regulator, and they display that licence number on their website and in their legal documents. Progestrade (CLONE) does not. The FXCanary Scam Risk Score of 55/100 (Elevated) reflects this vacuum. The score is not higher only because we have not yet documented active scams, such as fake withdrawal fees or manipulated trading platforms—but the absence of a licence is a red flag that should give any trader pause before funding an account.

In the absence of official documentation, we looked to aggregated industry data and web search results to see if any account tier information existed for Progestrade (CLONE). We found nothing that could be reliably attributed to this specific entity. Several search results pointed to similarly named firms, but none matched the official domain or the regulatory status we have on file. This is a common problem with clone brokers: they often share a name with a legitimate company, but the real firm's account details are not the same as the clone's. We therefore cannot state with any confidence what account types Progestrade (CLONE) offers, what the minimum deposit is, or what spreads you might expect.

For a trader, this lack of transparency is a dealbreaker. Even a new or small broker will typically publish at least a basic account comparison table. Progestrade (CLONE) offers nothing we can verify.

If you are approached by a representative of this firm and shown account terms, treat them with extreme caution. Ask for the regulatory licence number and the legal entity name, and verify them independently. If the broker cannot provide that, walk away.

Leverage is one of the most dangerous features of retail trading, and it becomes exponentially more dangerous when the broker is unregulated. In regulated jurisdictions, leverage is capped—for example, ESMA limits retail clients to 30:1 on major forex pairs, and ASIC has similar restrictions. These caps exist because high leverage can wipe out a retail account in a single trade. An unregulated broker has no such limits, and may offer leverage of 500:1 or even 1000:1 to attract clients, knowing that the odds are stacked against the trader.

We have no verified leverage figure for Progestrade (CLONE). The official domain does not disclose it, and our records do not include it. If the broker does offer high leverage, that is a further red flag, because it suggests a business model that profits from client losses rather than from transparent trading conditions. In FXCanary's assessment, any trader considering an account with this firm should assume that leverage, if offered, is not subject to any regulatory safeguard, and that the risk of losing your entire deposit is therefore significantly higher than with a regulated broker.

The cost of trading—spreads and commissions—is another area where Progestrade (CLONE) is silent. We found no published spread figures, no commission schedule, and no indication of whether the broker uses a dealing desk or a true ECN model. This is unusual even for a clone, because most fraudulent brokers will advertise razor-thin spreads to lure in clients, only to widen them dramatically once the account is funded. The absence of any such claims might mean the broker is not actively marketing yet, or it might mean that the website is a shell with no real trading backend.

For a trader, the lack of cost transparency is as concerning as the lack of regulation. You cannot evaluate whether a broker is competitive if you do not know what you will pay per trade. We recommend that any trader who is approached by Progestrade (CLONE) request a full schedule of spreads and commissions in writing, and then compare it against a regulated broker. If the numbers seem too good to be true, they almost certainly are.

A broker's trading platform is the window into the markets, and it is also a key indicator of legitimacy. Most reputable brokers offer MetaTrader 4 or MetaTrader 5, or a well-known proprietary platform, and they provide clear instructions for downloading and using it. For Progestrade (CLONE), we found no evidence of any trading platform. The official domain does not appear to offer a downloadable platform, a web trader, or a mobile app. This is a major red flag, because without a platform, there is no way to execute trades, and the entire operation may be a facade.

If the broker does offer a platform, it is likely to be a white-label solution or a custom web-based interface that is not subject to the same scrutiny as MetaTrader. Such platforms can be manipulated, with prices delayed or altered to trigger stop-losses and generate losses for the trader. In FXCanary's assessment, the absence of a verifiable platform is another reason to avoid this entity. A legitimate broker will always provide a platform that can be tested with a demo account, and that is recognised in the industry.

A demo account is the first step for most traders, and it is also a useful test of a broker's legitimacy. A reputable broker will offer a free demo account with virtual funds, allowing you to test the platform and the execution without risking real money. For Progestrade (CLONE), we found no evidence of a demo account offering. This is concerning, because a broker that does not offer a demo may be hiding poor execution conditions or may not have a functioning trading platform at all.

If you are considering this broker, we strongly advise you to ask for a demo account before depositing any funds. If the broker refuses, or if the demo experience is markedly different from what you would expect from a regulated broker, that is a clear signal to walk away. Remember, a demo account is not just a practice tool—it is a window into the broker's integrity. If the demo is manipulated, the live account will be too.

The account opening process at a legitimate broker involves a standard KYC procedure: you provide proof of identity and address, and the broker verifies your information before activating your account. This is a legal requirement in most jurisdictions, and it is designed to prevent money laundering and fraud. For Progestrade (CLONE), we have no information about the account opening process. The official domain does not appear to offer an online application, and we found no references to KYC requirements.

This is a double-edged sword. On one hand, the absence of KYC might mean the broker is not yet operational. On the other hand, it might mean that the broker is deliberately avoiding KYC to attract clients who want to trade anonymously, or to make it easier to launder money.

In either case, it is a red flag. A legitimate broker will always require KYC, and will be transparent about the documents you need to provide. If Progestrade (CLONE) does not ask for KYC, that is a sign that it is not operating to any recognised standard.

In FXCanary's assessment, Progestrade (CLONE) is a high-risk entity with no verifiable account information, no regulatory licence, and no trading platform. The FXCanary Scam Risk Score of 55/100 (Elevated) reflects the multiple red flags we have identified, but the true risk may be even higher. The name itself—with the '(CLONE)' suffix—suggests that this entity is impersonating a legitimate broker, which is a common tactic in the forex fraud landscape.

We cannot recommend that any trader open an account with this firm. If you have already done so, we urge you to withdraw your funds immediately and report the broker to your local financial regulator. For those who are considering trading with Progestrade (CLONE), we advise you to seek out a fully regulated broker with a verifiable track record. The few extra pips you might pay in spreads are a small price for the peace of mind that comes with knowing your funds are protected.